OptiBiotix Health (GB:OPTI) has released an update.
OptiBiotix Health’s recent study at Roehampton University shows that their product SlimBiome significantly reduces hunger and food cravings, promoting feelings of fullness, which may offer a natural and effective alternative to anti-obesity drugs. The study’s participants also experienced reductions in body fat and an improvement in mood, indicating a sustainable approach to weight management without the adverse effects commonly associated with anti-obesity medications. SlimBiome’s use in various food products could potentially tap into the burgeoning market for healthy weight management solutions.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.
